Today: 29 April 2026
Silver price tumbles again as CME margin hike and Fed chair pick spur liquidation fears
2 February 2026
2 mins read

Silver price tumbles again as CME margin hike and Fed chair pick spur liquidation fears

New York, February 2, 2026, 13:32 EST — Regular session

  • Spot silver dropped roughly 10%, adding to Friday’s record dive amid choppy trading
  • CME plans to implement higher margin requirements following Monday’s market close
  • Investors are reassessing U.S. rate risk following President Donald Trump’s appointment of Kevin Warsh to head the Fed

Spot silver plunged again Monday, dropping 10.4% to $75.79 an ounce by 11:00 a.m. ET after earlier tumbling as much as 15%. The metal’s rapid selloff erased last week’s blistering rally. It’s now down about 37% from the record $121.64 peak hit just last week, following Friday’s steep 27% drop.

How fast the move happens is just as important as where it lands. Traders are testing a crowded trade, and when forced selling kicks in, it can ripple across markets as positions get slashed to meet collateral demands.

Traders are zeroing in on the plumbing. CME Group’s hike in margin requirements — the cash needed to hold futures positions — comes as investors weigh Trump’s pick of Warsh to succeed Federal Reserve Chair Jerome Powell in May. “The decision by markets to sell precious metals alongside U.S. equities suggests investors view Warsh as more hawkish,” said Vivek Dhar, commodities strategist at Commonwealth Bank of Australia, citing pressure from higher-for-longer rates and a stronger dollar. Reuters

The selloff revealed just how quickly silver can reverse once momentum falters. After reaching a record high on January 29, technical selling and stop-loss orders kicked in, triggering what Reuters called the largest single-day drop in LSEG data going back to 1982. Analysts warned of a potential deeper slide, with a “fundamentally supported” price zone around $60-$70. Saxo Bank’s Ole Hansen pointed to a “massive” retail buying spree flooding the market. Reuters

The slump is hitting stocks linked to the metal. Denmark’s Pandora saw its shares jump up to 10% in Europe, fueled by hopes of lower input costs following silver’s decline. Jyske Bank analyst Janne Vincent Kjaer noted, “The sharp increase in the silver price has been a key concern in the market over the last couple of months,” as investors zero in on Pandora’s margins and hedging ahead of its Feb. 5 earnings. Reuters

Banks are recalibrating their forecasts after recent volatility. JP Morgan noted that silver’s drivers have become less predictable and pointed out the absence of structural central-bank backing that supports its gold outlook. Still, the bank expects silver to maintain a higher floor than previous cycles. “We still do see a higher floor for silver on average (around $75-$80/oz),” JP Morgan said. Reuters

The downside remains clear: if volatility stays elevated and the dollar continues to strengthen, traders could face another wave of liquidation, no matter the longer-term supply factors. In such a market, the chart outweighs the narrative.

The next hurdle arrives after Monday’s close, as CME’s increased margin requirements kick in. Investors are also waiting on clearer signals from U.S. macro data, with the Labor Department announcing that January’s employment report won’t drop Friday due to the partial government shutdown. That leaves markets without a crucial short-term gauge on growth and interest rates.

Stock Market Today

  • Mesoblast Shares Falter Amid Growing Uncertainty Over Growth Prospects
    April 28, 2026, 10:58 PM EDT. Mesoblast (ASX:MSB) shares closed at A$2.15, down 6.5% over the past week despite a 0.5% gain in the last day. The biopharma firm shows mixed signals: positive 1- and 3-year shareholder returns contrast with weaker short-term performance. Analysts highlight Mesoblast as 43.9% undervalued with a fair value target of A$3.83, driven by heart failure drug rexlemestrocel L, pending potential U.S. accelerated FDA approval. However, risks loom from slow Ryoncil sales and trial delays. Valuation models conflict; discounted cash flow suggests undervaluation at A$3.05, but a high price-to-sales ratio of 30.5x versus industry norms raises questions if the market overpays for growth or if assumptions are overstretched. Investors remain cautious amid uncertain future earnings and regulatory hurdles.

Latest article

AST SpaceMobile Stock’s May 11 Moment: FCC Win Meets BlueBird 7 Reality

AST SpaceMobile Stock’s May 11 Moment: FCC Win Meets BlueBird 7 Reality

29 April 2026
AST SpaceMobile will hold its first-quarter update call on May 11 after winning FCC approval to deploy a 248-satellite constellation for direct-to-device service. Shares fell 6.8% Tuesday, following the loss of its BlueBird 7 satellite in a failed launch. The company expects insurance to cover the loss and is targeting 45 satellites in orbit by end-2026. Investors are watching launch progress and commercial service timing.
OpenAI Target Miss Report Sends Oracle, CoreWeave and AI Stocks Lower

OpenAI Target Miss Report Sends Oracle, CoreWeave and AI Stocks Lower

29 April 2026
Oracle shares fell 4% and CoreWeave dropped 5.9% Tuesday after a Wall Street Journal report said OpenAI missed recent revenue and user targets. Nvidia, AMD, and Arm Holdings also declined, with the iShares Semiconductor ETF down 3.7%. OpenAI denied internal divisions and said its AI coding product Codex reached 4 million users. Oracle’s credit default swaps hit a two-week high amid concern over its $300 billion cloud deal with OpenAI.
Cisco stock pops to a fresh 52-week high — here’s what Wall Street is watching next
Previous Story

Cisco stock pops to a fresh 52-week high — here’s what Wall Street is watching next

Nebius (NBIS) stock rebounds after a wild session as Feb. 12 results loom
Next Story

Nebius (NBIS) stock rebounds after a wild session as Feb. 12 results loom

Go toTop